News & Media Press releases & statements Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Year All Years 2022 2021 2020 2019 2018 2017 2016 2015 Category All categories Type - Statement - Press release Topic - Corporate and finance - Global health - Partnerships Research area - COVID-19 - Ebola - RSV - Seasonal influenza Uncategorized Keywords Apply filter Advanced Search Search Search Headlines Only Type All Statement Press release Topic All Corporate and finance Global health Partnerships Research area All COVID-19 Ebola RSV Seasonal influenza From To Asset Types Photos Video Audio Documents Events Standard Jun 17, 2022 StatementCOVID-19Seasonal influenza Novavax to Showcase Innovative Vaccine Data at Communicable Diseases & Immunisation Conference 2022 Download Oct 15, 2021 COVID-19Seasonal influenza Novavax to Participate in World Vaccine Congress Europe Download Sep 23, 2021 Seasonal influenza Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases Download Jun 14, 2021 COVID-19Seasonal influenza Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously Download May 10, 2021 COVID-19Seasonal influenza Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate Download Oct 13, 2020 Seasonal influenza Novavax Appoints Leadership Team to Advance NanoFlu through Regulatory Licensure Download Mar 24, 2020 Seasonal influenza Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial Download Feb 25, 2020 Seasonal influenza Novavax’ Preclinical NanoFlu Data Published in Vaccines; Details Structural Basis for Broadly Neutralizing Immunity Download Jan 15, 2020 Seasonal influenza Novavax Granted Fast Track Designation for NanoFlu in Older Adults Download Oct 15, 2019 Seasonal influenza Novavax Initiates Pivotal Phase 3 Clinical Trial of NanoFlu Influenza Vaccine in Older Adults Download Aug 5, 2019 Seasonal influenza Novavax Reaches Agreement with the FDA on Pivotal Phase 3 Trial Design for NanoFlu Download Jun 27, 2019 Seasonal influenza Novavax Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu™ Download Jun 4, 2019 Seasonal influenza Novavax CFO John Trizzino to Discuss Future of Influenza Vaccines on Industry Panel at 2019 BIO International Convention Download Jan 3, 2019 Seasonal influenza Novavax Announces Positive Phase 2 NanoFlu Results in Older Adults Download Sep 25, 2018 Seasonal influenza Novavax Initiates Phase 2 Clinical Trial of NanoFlu™ in Older Adults Download Jun 13, 2018 Seasonal influenza New England Journal of Medicine Publishes Novavax’ NanoFlu Clinical Trial Data Download Apr 2, 2018 Seasonal influenza Novavax to Present Clinical Data on RSV F and NanoFlu™ Vaccines at World Vaccine Congress Download Feb 28, 2018 Seasonal influenza Novavax NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine Download Sep 19, 2017 Seasonal influenza Novavax Initiates Phase 1/2 Trial of NanoFlu™ Vaccine in Older Adults Download Aug 23, 2017 Seasonal influenza Novavax’ Preclinical Influenza Nanoparticle Study Published in Vaccine Download Jul 30, 2015 Seasonal influenza Novavax Announces Positive Data From Phase 2 Trial of Quadrivalent Seasonal Influenza VLP Download Show 5102550100 per page